Published results showed umbilical cord-derived platelet-rich plasma provided better short-term pain relief but similar ...
Aficamten, a first-in-class cardiac myosin inhibitor, offers a new treatment option for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Clinical trials SEQUOIA-HCM and MAPLE-HCM showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results